Charcot-Marie-Tooth (CMT) is the most common inherited neuropathy, with an overall prevalence estimated at 10-28/100000 [1]. It is characterized by sensorimotor impairment of the extremities, skeletal deformities and functional limitations [2]. Although it is considered a rare disease, it is more frequently diagnosed than in the past due to increased awareness and availability of genetic testing [3]. Unfortunately, improvements in diagnosis have been not followed by improvements in therapy. Rehabilitation and surgical treatment remain the only option and no pharmacologic disease modifying therapies are available.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...